Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
25.00
+0.84 (3.48%)
At close: Aug 22, 2025, 4:00 PM
25.00
0.00 (0.00%)
After-hours: Aug 22, 2025, 4:30 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $362.14 million as of August 22, 2025. Its market cap has increased by 118.29% in one year.
Market Cap
362.14M
Enterprise Value
282.36M
1-Year Change
118.29%
Ranking
Category
Stock Price
$25.00
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $362.14M, an increase of 82.68%. That is a compound annual growth rate of 63.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 362.14M | 62.44% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |